Loading insider details...
Beta
Latest Form 4 (May 22, 2026): Grant/Award of 15,000 ACTU shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 22, 2026 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/Award | 15,000 | n/a |
| Feb 6, 2026 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 24,000 | n/a |
| Jan 6, 2026 | Mersana Therapeutics, Inc. (MRSN) | Tender of Shares | 9,573 | n/a |
| Sep 15, 2025 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 6,670 | n/a |
| May 19, 2025 | Syndax Pharmaceuticals Inc (SNDX) | Purchase | 5,000 | $45.0K |
| Feb 7, 2025 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 25,000 | n/a |
| Jan 18, 2025 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 11,062 | n/a |
| Sep 13, 2024 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 166,750 | n/a |
| Feb 9, 2024 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 17,000 | n/a |
| Jan 17, 2024 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 199,125 | n/a |